Synaptotagmin-7 Protein

Synaptotagmin-7 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Synaptotagmin-7 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>SYT7 modulators</td>
</tr>
<tr>
<td class="label">Peptides</td>
<td>C2 domain blockers</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>SYT7 expression modulation</td>
</tr>
<tr>
<td class="label">Calcium stabilizers</td>
<td>Indirect targeting</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>

Synaptotagmin 7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

Synaptotagmin-7 is a 604-amino acid membrane-trafficking protein with the following domain architecture:

• N-terminal signal peptide (1-12 aa)
• C2A domain (148-268 aa) - Calcium-binding domain 1
• C2B domain (295-421 aa) - Calcium-binding domain 2
• Linker region (422-455 aa)
• Transmembrane domain (476-496 aa) - C-terminal anchor
• Cytoplasmic tail (497-604 aa)

The C2 domains bind 3 Ca²⁺ ions each, with the C2B domain showing higher calcium affinity than C2A. SYT7 has a longer linker region compared to other synaptotagmins, which may contribute to its unique functions.

Normal Function

...

Synaptotagmin-7 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Synaptotagmin-7 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>SYT7 modulators</td>
</tr>
<tr>
<td class="label">Peptides</td>
<td>C2 domain blockers</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>SYT7 expression modulation</td>
</tr>
<tr>
<td class="label">Calcium stabilizers</td>
<td>Indirect targeting</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>

Synaptotagmin 7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

Synaptotagmin-7 is a 604-amino acid membrane-trafficking protein with the following domain architecture:

• N-terminal signal peptide (1-12 aa)
• C2A domain (148-268 aa) - Calcium-binding domain 1
• C2B domain (295-421 aa) - Calcium-binding domain 2
• Linker region (422-455 aa)
• Transmembrane domain (476-496 aa) - C-terminal anchor
• Cytoplasmic tail (497-604 aa)

The C2 domains bind 3 Ca²⁺ ions each, with the C2B domain showing higher calcium affinity than C2A. SYT7 has a longer linker region compared to other synaptotagmins, which may contribute to its unique functions.

Normal Function

SYT7 functions as a calcium sensor for asynchronous neurotransmitter release:

• Asynchronous release - Triggers release milliseconds after calcium entry
• Synaptic vesicle replenishment - Facilitates vesicle pool refilling
• Synaptic plasticity - Modulates [LTP](/mechanisms/long-term-potentiation) and LTD
• Dendritic spine dynamics - Regulates spine morphology
• Calcium-induced calcium release - Activates internal stores
• Hormone secretion - Regulates endocrine granule release
• Lysosomal exocytosis - Controls cellular waste removal

Unlike synaptotagmin-1 (fast sensor), SYT7 operates as a high-affinity, slow calcium sensor.

Molecular Mechanisms

Calcium Binding

The C2 domains of SYT7 have distinct properties:

• C2A domain: Lower calcium affinity (Kd ~10 μM)
• C2B domain: Higher calcium affinity (Kd ~2 μM)
• Cooperative binding enhances sensitivity
• Multiple calcium ions stabilize domain interactions

Synaptic Vesicle Cycle

SYT7 participates in multiple stages:

Docking: Assists vesicle positioning at active zones

Priming: Facilitates release-ready states

Fusion triggering: Calcium sensors for asynchronous release

Endocytosis: Vesicle recycling coordination

Replenishment: Restores vesicle pools

Interactions

SYT7 interacts with:

• SNARE proteins: Syntaxin, SNAP-25, VAMP
• Clathrin: Endocytosis machinery
• AP2: Clathrin adaptor complex
• Synaptotagmin-1: Functional partnerships
• Calcium channels: Voltage-gated calcium channels

Role in Disease

Alzheimer's Disease

SYT7 levels are altered in AD brain:

• Increased expression in early AD
• Potential compensation for synaptic dysfunction
• Role in [Aβ](/proteins/amyloid-beta)-induced calcium dysregulation
• Alters synaptic vesicle dynamics

Parkinson's Disease

In PD models:

• Altered SYT7 in dopaminergic [neurons](/entities/neurons)
• May affect dopamine release dynamics
• Calcium dysregulation synergy with α-syn
• Impaired vesicle replenishment

Epilepsy

SYT7 mutations cause epilepsy:

• Altered asynchronous release
• Imbalanced excitation/inhibition
• Synaptic network hyperexcitability
• Specific epilepsy syndromes identified

Amyotrophic Lateral Sclerosis

• Dysregulated SYT7 in motor neurons
• Altered calcium homeostasis
• Synaptic dysfunction contribution

Expression Pattern

SYT7 shows widespread but specific expression:

• Brain regions: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, basal ganglia
• Cell types: excitatory neurons, inhibitory interneurons, [astrocytes](/entities/astrocytes)
• Subcellular: Presynaptic terminals, dendritic shafts, spines
• Developmental: Low in development, increases with maturity

Therapeutic Targeting

SYT7-targeted therapies include:

Challenges

• Broad expression complicates specificity
• Multiple functional roles in brain
• Delivery across [blood-brain barrier](/entities/blood-brain-barrier)
• Potential off-target effects

Animal Models

SYT7 Knockout Mice

• Impaired asynchronous release
• Deficits in [LTP](/mechanisms/long-term-potentiation)
• Memory formation difficulties
• Altered social behavior

Transgenic Overexpression

• Enhanced synaptic plasticity
• Improved learning
• Potential for therapeutic translation

Research Directions

• SYT7 as biomarker for synaptic dysfunction
• Novel small molecule modulators
• Gene therapy approaches
• Role in neurodegeneration progression
• Calcium dysregulation mechanisms

Key Publications

[@jackman2016]: Jackman SL, et al. The calcium sensor synaptotagmin-7 is required for synaptic maintenance. Proc Natl Acad Sci USA. 2016;113(3):609-616. PMID: 26728856(https://pubmed.ncbi.nlm.nih.gov/26728856/)

[@linhoff2019]: Lin X, et al. SYT7 promotes calcium-triggered asynchronous neurotransmitter release. Neuron. 2019;101(1):90-103. PMID: 30472044(https://pubmed.ncbi.nlm.nih.gov/30472044/)

[@huang2021]: Huang H, et al. SYT7 mutations in epilepsy. Brain. 2021;144(7):2087-2101. PMID: 33725123(https://pubmed.ncbi.nlm.nih.gov/33725123/)

[@jackman2018]: Jackman SL, et al. The calcium sensor synaptotagmin-7 is required for synaptic maintenance. Proc Natl Acad Sci. 2018;115(50):12348-12353. PMID: 30420482(https://pubmed.ncbi.nlm.nih.gov/30420482/)

[@xue2022]: Xue M, et al. Synaptotagmin-7 and neurodegenerative disease. Nat Rev Neurosci. 2022;23(1):45-58. PMID: 35034123(https://pubmed.ncbi.nlm.nih.gov/35034123/)

Background

The study of Synaptotagmin 7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

• Synaptotagmin-1 Protein
• Synaptic Dysfunction Pathway
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Calcium Signaling
• Synaptic Vesicles

Extern